LLY
1,040.03
+0.29%↑
JNJ
243.3
-0.53%↓
ABBV
231.41
+1.75%↑
NVS
162.81
+1.21%↑
MRK
121.33
+1.83%↑
LLY
1,040.03
+0.29%↑
JNJ
243.3
-0.53%↓
ABBV
231.41
+1.75%↑
NVS
162.81
+1.21%↑
MRK
121.33
+1.83%↑
LLY
1,040.03
+0.29%↑
JNJ
243.3
-0.53%↓
ABBV
231.41
+1.75%↑
NVS
162.81
+1.21%↑
MRK
121.33
+1.83%↑
LLY
1,040.03
+0.29%↑
JNJ
243.3
-0.53%↓
ABBV
231.41
+1.75%↑
NVS
162.81
+1.21%↑
MRK
121.33
+1.83%↑
LLY
1,040.03
+0.29%↑
JNJ
243.3
-0.53%↓
ABBV
231.41
+1.75%↑
NVS
162.81
+1.21%↑
MRK
121.33
+1.83%↑
24 ч
Текуща
Минимум
80.84
Максимум
83.82
Препоръки | Силна покупка |
|---|---|
12-месечна прогноза | +116.74% upside |
Следващи печалби | 30.03.2026 г. |
|---|
By Acuity
50%
50%
127 / 351 Класиране в Healthcare
Миналото представяне не гарантира бъдещи резултати.
15.02.2026 г., 23:21 ч. UTC
Qube Agrees to Takeover by MAM-Led Consortium Valuing Its Equity at $6.51 Billion
DJ
Прочетени
15.02.2026 г., 23:45 ч. UTC
Nikkei May Rise as Fears About AI Disruption Recede -- Market Talk
DJ
Прочетени
15.02.2026 г., 23:40 ч. UTC
Gold Falls on Possible Position Adjustments -- Market Talk
DJ
Прочетени
15.02.2026 г., 23:06 ч. UTC
Thai Beverage: Spirits, Beer Businesses Posted Satisfactory EBITDA Growth, Alongside Profit Margin Expansion>Y92.SG
DJ
Прочетени
15.02.2026 г., 23:04 ч. UTC
Thai Beverage 1Q Beer Business EBITDA THB4.64B, Up 4.7% on Year>Y92.SG
DJ
Прочетени
15.02.2026 г., 23:04 ч. UTC
Thai Beverage 1Q Spirits Business EBITDA THB8.50B, Up 6.9% on Year >Y92.SG
DJ
Прочетени
15.02.2026 г., 23:01 ч. UTC
Thai Beverage 1Q EBITDA THB16.75B, Up 1.8% on Year >Y92.SG
DJ
Прочетени
15.02.2026 г., 23:01 ч. UTC
Thai Beverage 1Q FY Sales Revenue THB86.70B, Down 6.0% on Year>Y92.SG
DJ
Прочетени
15.02.2026 г., 22:53 ч. UTC
Qube: MAM-Led Offer Implies A$11.7 Billion Enterprise Value
DJ
Прочетени
15.02.2026 г., 22:53 ч. UTC
Qube: UniSuper to Transfer 15.07% Stake to Equivalent Ownership of Consortium Holding Structure
DJ
Прочетени
15.02.2026 г., 22:52 ч. UTC
Qube Shareholders to Receive A$5.20/Share in Cash
DJ
Прочетени
15.02.2026 г., 22:52 ч. UTC
Qube Holdings Agrees to Takeover by Macquarie Asset Management-Led Consortium
DJ
Прочетени
15.02.2026 г., 22:22 ч. UTC
BlueScope CEO Tania Archibald Speaking on a Call With Media
DJ
Прочетени
15.02.2026 г., 22:17 ч. UTC
BlueScope CEO: Stresses Whyalla Project Would Have to Make Sense to Shareholders
DJ
Прочетени
15.02.2026 г., 22:16 ч. UTC
BlueScope CEO: Some Job Cuts Inevitable to Ensure Company is Competitive
DJ
Прочетени
15.02.2026 г., 22:14 ч. UTC
BlueScope CEO: Higher Returns Tied to End of Capital Investment Program
DJ
Прочетени
15.02.2026 г., 22:14 ч. UTC
BlueScope Steel CEO: Higher Returns After Rebuffed Takeover Bid a 'Natural Coincidence'
DJ
Прочетени
15.02.2026 г., 20:48 ч. UTC
BlueScope: Will Now Target Net Debt of Up to A$1.5 Billion; Will Surpass as Needed
DJ
Прочетени
15.02.2026 г., 20:47 ч. UTC
BlueScope: Expects Full Benefits of Further A$150M Cost Savings in FY 2027
DJ
Прочетени
15.02.2026 г., 20:46 ч. UTC
BlueScope: Recorded Net Annualized Cost Improvements of A$190 Million in 1H
DJ
Прочетени
15.02.2026 г., 20:45 ч. UTC
BlueScope Expects a One-Third Lower 2H Result From Asia Business Vs 1H
DJ
Прочетени
15.02.2026 г., 20:44 ч. UTC
BlueScope Expects 15% Higher 2H Result From North America Business Vs 1H
DJ
Прочетени
15.02.2026 г., 20:44 ч. UTC
BlueScope Expects Lower 2H Result From Australia Business Vs 1H
DJ
Прочетени
15.02.2026 г., 20:43 ч. UTC
BlueScope Expects 2H Underlying Ebit of A$620 Million-A$700 Million
DJ
Прочетени
15.02.2026 г., 20:42 ч. UTC
BlueScope Net Debt A$2.2 Million at Dec. 31
DJ
Прочетени
15.02.2026 г., 20:42 ч. UTC
BlueScope 1H Underlying Ebit A$557.5 Million, Up 81% On-Year
DJ
Прочетени
15.02.2026 г., 20:41 ч. UTC
BlueScope 1H Underlying Ebitda A$915.3 Million, Up 39% On-Year
DJ
Прочетени
15.02.2026 г., 20:40 ч. UTC
BlueScope 1H Underlying Profit A$382.0 Million Vs A$176.4 Million Year Prior
DJ
Прочетени
15.02.2026 г., 20:40 ч. UTC
BlueScope 1H Sales Revenue From Continuing Ops A$8.22 Billion, Up 4% On-Year
DJ
Прочетени
15.02.2026 г., 20:39 ч. UTC
BlueScope Intends to Spend A$310 Million on Buyback, Or Other Returns if Share Repurchases Limited
DJ
Прочетени
Ценова промяна
By TipRanks
12-месечна прогноза
Среден 176.73 USD 116.74%
Висок 212 USD
Нисък 76.43 USD
Според 15 анализатори от Wall Street, предложили 12-месечна ценова цел за Palvella Therapeutics Inc през последните три месеца.
By TipRanks
Силна покупка
15 ratings
15
Купи
0
Задържане
0
Продай
Според 15 анализатори, дали борсови рейтинги на Palvella Therapeutics Inc през последните 3 месеца.
By Acuity
Настроения в новините
Neutral
Волатилност
Под средното
Обем новини (RCV)
Над средното
$